13F HOLDINGS REPORT
Pfizer Inc
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000078003-25-000048
Total Value
$2.59B
Positions
26
Other Managers
0
Confidential Omitted
No
Holdings (26)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HALEON PLC | HLNCF | 197,228,952 | $1.88B | 72.59% |
| 2 | BIONTECH SE | BNTX | 3,658,361 | $416.9M | 16.08% |
| 3 | ARVINAS INC | ARVN | 3,457,815 | $66.3M | 2.56% |
| 4 | ALLOGENE THERAPEUTICS INC | ALLO | 22,032,040 | $46.9M | 1.81% |
| 5 | ORIC PHARMACEUTICALS INC | ORIC | 5,376,344 | $43.4M | 1.67% |
| 6 | TOURMALINE BIO INC | 89157D105 | 1,272,214 | $25.8M | 1.00% |
| 7 | WAVE LIFE SCIENCES LTD | WVE | 1,875,000 | $23.2M | 0.89% |
| 8 | BIOHAVEN LTD | BHVN | 505,645 | $18.9M | 0.73% |
| 9 | AKERO THERAPEUTICS INC | 00973Y108 | 562,626 | $15.7M | 0.60% |
| 10 | CARDIFF ONCOLOGY INC | CRDF | 2,411,575 | $10.5M | 0.40% |
| 11 | PYXIS ONCOLOGY INC | PYXS | 5,952,263 | $9.3M | 0.36% |
| 12 | CARIBOU BIOSCIENCES INC | CRBU | 4,690,431 | $7.5M | 0.29% |
| 13 | ZURA BIO LTD | ZURA | 2,970,022 | $7.4M | 0.29% |
| 14 | CELCUITY INC | CELC | 349,406 | $4.6M | 0.18% |
| 15 | ESSA PHARMA INC | 29668H708 | 1,675,000 | $3.0M | 0.12% |
| 16 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 953,834 | $2.9M | 0.11% |
| 17 | SPERO THERAPEUTICS INC | SPRO | 2,362,348 | $2.4M | 0.09% |
| 18 | PYXIS ONCOLOGY INC | PYXS | 1,080,507 | $1.7M | 0.07% |
| 19 | NEXTCURE INC | NXTC | 1,213,024 | $1.6M | 0.06% |
| 20 | AN2 THERAPEUTICS INC | ANTX | 715,295 | $987,107 | 0.04% |
| 21 | Q32 BIO INC | QTTB | 277,777 | $955,553 | 0.04% |
| 22 | BOLT BIOTHERAPEUTICS INC | BOLT | 626,109 | $335,031 | 0.01% |
| 23 | NEXTCURE INC | NXTC | 245,526 | $318,451 | 0.01% |
| 24 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 2,681 | $26,328 | 0.00% |
| 25 | SENSEONICS HLDGS INC | SENS | 43,426 | $22,729 | 0.00% |
| 26 | GINKGO BIOWORKS HOLDINGS INC | DNABW | 247 | $2,426 | 0.00% |